Monopar Therapeutics Inc (MNPR)
0.61
-0.01
(-1.21%)
USD |
NASDAQ |
May 17, 16:00
0.61
0.00 (0.00%)
After-Hours: 20:00
Monopar Therapeutics Enterprise Value: 1.872M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.872M |
| May 16, 2024 | 2.003M |
| May 15, 2024 | 1.664M |
| May 14, 2024 | 2.589M |
| May 13, 2024 | 3.010M |
| May 10, 2024 | 2.960M |
| May 09, 2024 | 3.640M |
| May 08, 2024 | 4.320M |
| May 07, 2024 | 4.530M |
| May 06, 2024 | 5.054M |
| May 03, 2024 | 3.921M |
| May 02, 2024 | 2.746M |
| May 01, 2024 | 2.571M |
| April 30, 2024 | 2.748M |
| April 29, 2024 | 2.571M |
| April 26, 2024 | 2.715M |
| April 25, 2024 | 2.178M |
| April 24, 2024 | 2.694M |
| April 23, 2024 | 2.571M |
| April 22, 2024 | 2.257M |
| April 19, 2024 | 2.398M |
| April 18, 2024 | 3.061M |
| April 17, 2024 | 2.659M |
| April 16, 2024 | 3.935M |
| April 15, 2024 | 4.407M |
| Date | Value |
|---|---|
| April 12, 2024 | 4.862M |
| April 11, 2024 | 4.670M |
| April 10, 2024 | 2.397M |
| April 09, 2024 | 1.533M |
| April 08, 2024 | 1.715M |
| April 05, 2024 | 1.732M |
| April 04, 2024 | 2.369M |
| April 03, 2024 | 2.432M |
| April 02, 2024 | 2.397M |
| April 01, 2024 | 3.078M |
| March 28, 2024 | 4.621M |
| March 27, 2024 | 5.598M |
| March 26, 2024 | 5.586M |
| March 25, 2024 | 5.127M |
| March 22, 2024 | 4.771M |
| March 21, 2024 | 4.954M |
| March 20, 2024 | 6.125M |
| March 19, 2024 | 6.024M |
| March 18, 2024 | 4.429M |
| March 15, 2024 | 4.097M |
| March 14, 2024 | 5.074M |
| March 13, 2024 | 5.862M |
| March 12, 2024 | 7.152M |
| March 11, 2024 | 8.646M |
| March 08, 2024 | 6.988M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.194M
Minimum
Nov 20 2023
276.87M
Maximum
Dec 20 2019
33.02M
Average
23.48M
Median
Enterprise Value Benchmarks
| Motus GI Holdings Inc | -2.136M |
| SeaStar Medical Holding Corp | 38.04M |
| Perspective Therapeutics Inc | 817.27M |
| Electromed Inc | 130.07M |
| Xtant Medical Holdings Inc | 116.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.641M |
| Total Expenses (Quarterly) | 1.723M |
| EPS Diluted (Quarterly) | -0.10 |
| Earnings Yield | -85.25% |